Tom is COO & Co-Founder of Maxwell Plus. He leads the company’s growth, patient experience, and regulatory compliance. He has helped Maxwell Plus become the world’s first AI medical device for prostate cancer and Australia’s largest prostate cancer testing clinic. Before Maxwell Plus, Tom founded a tech company focused on helping children with Cystic Fibrosis and was an Associate with McKinsey & Company.

Tom is passionate about AI and digital health’s impact on patient outcomes. Seeing the impact Maxwell Plus’ technology has had in Australia, he is excited to bring the service to the UK and other countries.